<DOC>
	<DOCNO>NCT01697956</DOCNO>
	<brief_summary>The purpose study compare effect 6 week treatment beclomethasone dipropionate ( BDP ) nasal aerosol versus placebo HPA-axis function , assess 24-hour serum cortisol weight mean , evaluate safety tolerability BDP nasal aerosol , subject 6 11 year age perennial allergic rhinitis .</brief_summary>
	<brief_title>Hypothalamic-Pituitary-Adrenal ( HPA ) -Axis Study Pediatric Subjects With Perennial Allergic Rhinitis ( PAR )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Informed consent/ ( assent applicable ) Male female subject 611 year age General good health A documented history PAR relevant perennial allergen minimum 12 month Other criterion apply Pregnancy , nursing , plan become pregnant donate gamete Participation investigational drug study within 30 day precede Screening Visit 1 ( SV1 ) Previous participation BDP nasal aerosol study randomize subject A known hypersensitivity corticosteroid excipients study medication formulation History physical finding nasal pathology , include nasal polyp clinically significant respiratory tract malformation History respiratory infection disorder within 14 day precede Screening Visit 1 ( SV1 ) Use prohibit concomitant medication within prescribe ( per protocol ) withdrawal period prior Screening Visit 1 ( SV1 ) Other criterion apply Current smoker current user tobacco product time study ; history smoking use tobacco product within past year</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Pediatric Subjects</keyword>
</DOC>